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Background: Epidemiologic observations indicate that the number of systemic fungal infec-
tions has increased significantly during the past decades, however in human mycosis, mainly 
cutaneous infections predominate, generating major public health concerns and providing much 
of the impetus for current attempts to develop novel and efficient agents against cutaneous 
mycosis causing species. Innovative, environmentally benign and economic nanotechnology-
based approaches have recently emerged utilizing principally biological sources to produce 
nano-sized structures with unique antimicrobial properties. In line with this, our aim was to 
generate silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) by biological synthesis 
and to study the effect of the obtained nanoparticles on cutaneous mycosis causing fungi and 
on human keratinocytes.
Methods: Cell-free extract of the red yeast Phaffia rhodozyma proved to be suitable for nano-
particle preparation and the generated AgNPs and AuNPs were characterized by transmission 
electron microscopy, dynamic light scattering and X-ray powder diffraction.
Results: Antifungal studies demonstrated that the biosynthesized silver particles were able to 
inhibit the growth of several opportunistic Candida or Cryptococcus species and were highly 
potent against filamentous Microsporum and Trichophyton dermatophytes. Among the tested 
species only Cryptococcus neoformans was susceptible to both AgNPs and AuNPs. Neither 
AgNPs nor AuNPs exerted toxicity on human keratinocytes.
Conclusion: Our results emphasize the therapeutic potential of such biosynthesized nanopar-
ticles, since their biocompatibility to skin cells and their outstanding antifungal performance 
can be exploited for topical treatment and prophylaxis of superficial cutaneous mycosis.
Keywords: antifungal activity, biological synthesis, dermatophytes, opportunistic pathogenic 
yeasts, silver nanoparticles, toxicity
Introduction
Due to social and global environmental changes, the aging population and the grow-
ing number of susceptible individuals (eg, patients with predisposing factors), the 
incidence of superficial mycosis has increased over the past few years causing health 
problems world-wide.1,2 Dermatomycosis usually manifests as itchy, sore skin rashes 
and tinea on the toes, the inner thighs or groin; leading to flaking and blistering of the 
affected area. Fungi may spread to the scalp or nails causing hair loss and thickened or 
deformed fingernails. The etiological agents behind dermatomycosis are mostly fila-
mentous dermatophytes (eg, Microsporum spp., Trichophyton spp. or Epidermophyton 
spp.), however, several opportunistic yeast species such as Candida or Cryptococcus 
can invade keratinized tissues.1,3 In case of cutaneous candidiasis, the origin is mostly 
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endogenous as the causative agents (ie, Candida spp.) are 
the resident or transient members of the human dermal 
microflora. Cryptococcus neoformans can induce meningitis 
in immunocompromised patients, however, due to systemic 
dissemination of yeast cells in such patients, skin lesions may 
also appear.4 In addition to this secondary variant, a primary 
form of cutaneous cryptococcosis has recently been identi-
fied, where the pathogen enters the body directly through skin 
injury.5 Regardless of the distinct origins of Cr. neoformans 
infections, this pathogen can cause life-threatening systemic 
complications in the host.4,5 Therefore, there is an inevitable 
and urgent medical need to find novel and efficient agents 
to defeat opportunistic pathogens and cutaneous mycosis-
causing species. To achieve this goal, an innovative, envi-
ronmentally benign and economic approach is required.
A solution that fulfills these demands could be based 
on nanotechnology, since owing to the abundance of recent 
scientific advancements in this field, it is now possible 
to design and develop nano-sized structures with unique 
properties tailored for specific applications (eg, in optics, in 
electronics, in catalysis, and in household items, as well as in 
medicine).6 In recent years, gold nanoparticles (AuNPs) and 
silver nanoparticles (AgNPs),7 in particular, have been in the 
focus of increasing interest due to their simple synthesis and 
desirable biological activities (ie, antitumor, antibacterial, 
antiviral and antifungal effects).8,9 We have reported that 
the cytotoxic features of AgNPs can be exploited to kill p53 
tumor suppressor-deficient10 as well as multidrug-resistant 
cancer cells,11 providing some further details to the mecha-
nism of AgNP-induced antitumor actions. In recent years, 
several studies have also demonstrated that AgNPs, synthe-
sized either by conventional chemical reduction methods, 
physical techniques or by different biological entities, exhibit 
potent inhibitory effects against Gram positive and Gram 
negative bacterial species and induce cytotoxicity in various 
pathogenic fungi.8,12 Green alternatives to harsh reducing 
chemicals and environmentally benign capping agents have 
also been developed to reduce the costs of nanoparticle pro-
duction and to minimize the generation of hazardous wastes 
upon the synthetic procedures.13 In a comprehensive study 
on AgNPs obtained by chemical reduction using coffee and 
green tea extracts, we proved the remarkable antimicrobial 
efficiency of such particles,14 and we showed evidence that 
the green material used for AgNP synthesis can largely define 
the physical, chemical and biological characteristics of the 
produced nanomaterial.14
Owing to widespread applications, there is an ever-growing 
demand for AgNPs and AuNPs, while the challenges of their 
economical, environmentally safe and sustainable production 
should also be addressed. A rapidly progressing area of nano-
biotechnology is the microbe-assisted nanoparticle synthesis,15 
where bacterial strains, yeast- and alga-mediated reactions are 
exploited for nanoparticle generation.16,17 One such study dem-
onstrated that the astaxanthin-containing green alga Chlorella 
vulgaris is a useful agent for gold nanoparticle synthesis.18 
Based on this observation we hypothesized that Phaffia rho-
dozyma (perfect state Xanthophyllomyces dendrorhous), a 
basidiomycetous red yeast with high astaxanthin content,19 
might also be a potential candidate for microbe-assisted nano-
particle synthesis. Therefore, the aim of this present study was 
to investigate the suitability of P. rhodozyma cell-free extract 
for the preparation of AgNPs and AuNPs. Since our synthesis 
method proved to be successful, the as-prepared nanoparticles 
were characterized, and a complex biological screening was 
carried out to determine their biological activity, where beside 
toxicity to human skin-derived cells, the antifungal efficiency 
of the bio-synthesized nanoparticles was also assessed with a 
special emphasis on inhibitory features against opportunistic 
pathogenic yeasts and dermatophytes.
Materials and methods
Preparation of P. rhodozyma cell-free 
extract
P. rhodozyma American Type Culture Collection (ATCC) 
24203 cells grown on 2× yeast extract peptone dextrose 
(YPD; Sigma-Aldrich Co., St Louis, MO, USA) (2% 
D-glucose, 2% peptone, 1% yeast extract and 2% agar) plates 
at 22°C for 5 days were collected by cell scraper. Ten grams 
of wet weight biomass were suspended in 200 mL sterile 
distilled water and the cells were disrupted in Bead Beater 
(BioSpec Products, Inc., Bartlesville, OK, USA) using glass 
beads with 0.5–1 mm diameter. Cell debris was removed 
by centrifugation at 18,000 g for 15 min in Sorvall RC-5B 
centrifuge (Thermo Fisher Scientific, Waltham, MA, USA) 
at 4°C. The supernatant was filtered through 0.45 µm pore 
sized nitrocellulose membrane (Merck KGaA, Darmstadt, 
Germany). The filtrate was used as a reducing agent and 
stabilizer for the synthesis of nanoparticles.
synthesis of agNPs and auNPs
After optimization of the nanoparticle synthesis process, 
the following protocol was used. For preparation of AgNP, 
90 mL cell-free extract (pH 6.7) was mixed with 10 mL of 
1 M AgNO
3
 suspension. Gold nanoparticles were synthesized 
similarly, by adding 10 mL 1 M HAuCl
4
 solution to 90 mL 
cell-free extract. Both suspensions were constantly stirred 
using an orbital shaker at 22°C for 24 hours. Nanoparticles 
were pelleted by centrifugation for 15 min at 18,000 g in 
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Sorvall RC-5B centrifuge at 4°C then washed twice with 
sterile distilled water. The final colloid suspensions were 
characterized and stored at 4°C.
characterization of nanoparticles
The morphological features of the synthesized AgNPs and 
AuNPs were analyzed by transmission electron microscopy 
(TEM) using a FEI Tecnai G2 20 microscope (FEI Corporate 
Headquarters, Hillsboro, OR, USA) at an acceleration voltage 
of 200 kV. The hydrodynamic particle size distribution of 
the samples was assessed by dynamic light scattering (DLS) 
analysis using a Zetasizer Nano Instrument (Malvern Instru-
ments, Malvern, UK). The crystal structures were examined 
by X-ray powder diffraction (XRD), where the scans were 
performed with a Rigaku MiniFlex II powder diffractometer 
(Rigaku Corporation, Tokyo, Japan) using Cu Kα radia-
tion. A scanning rate of 2° min-1 in the 20°–80° 2θ range 
was used. Finally, the optical properties of the obtained 
AuNPs and AgNPs were studied using an Ocean Optics 355 
DH-2000-BAL ultraviolet-visible (UV-VIS) spectrophotom-
eter (Halma PLC, Largo, FL, USA) in a 10-mm path length 
quartz cuvette. The absorbance spectra of nanoparticles 
were recorded within the range of 300–800 nm.
cell culture
HaCaT immortalized keratinocyte cell line from adult human 
skin was purchased from ATCC. HaCaT cells were main-
tained in Dulbecco’s Modified Eagle’s Medium (DMEM) 
containing 4.5 g/L glucose, supplemented with 10% fetal 
bovine serum, 2 mM L-glutamine, 0.01% streptomycin and 
0.005% ampicillin. Cells were cultured under standard condi-
tions in a 37°C incubator at 5% CO
2
 in 95% humidity.
cell viability and toxicity assays
MTT mitochondrial activity assay (Sigma-Aldrich) was 
performed to measure cell viability. HaCaT cells were 
seeded into 96 well plates (10,000/wells) and treated with 
either AgNPs or AuNPs, or with cisplatin in different con-
centrations on the following day. After 24-hour treatments 
cells were washed with phosphate buffered saline (PBS) 
and incubated with culture medium containing 0.5 mg/mL 
MTT reagent for 1 hour at 37°C. Formazan crystals were 
solubilized in DMSO and extinction was measured at 570 nm 
using a Synergy HTX plate reader (Thermo Fisher Scientific). 
Absorption corresponding to the untreated control samples 
was considered as 100%. MTT assays were performed at least 
three times using four independent biological replicates.
Cytotoxicity of the synthesized nanoparticles was 
assessed by crystal violet staining as well. For this, HaCaT 
cells were seeded into 24 well plates and were left to grow 
until they reached confluence. Then cell layers were treated 
with nanoparticles or with cisplatin for 24 hours. After each 
treatment, cells were washed three times with PBS and fixed 
using methanol:acetone 70:30 mixture. Fixed cells were then 
stained using 0.5% crystal violet dissolved in 25% methanol, 
washed with distilled water then air-dried. Plates were photo-
graphed, and crystal violet was solubilized using 400 µL 10% 
acetic acid. From each well, 100 µL solution was transferred 
to 96 well plates then absorbance was determined at 590 nm 
using a the HTX microplate reader.
screening of antifungal activity
The antifungal activity of the nanoparticles was tested against 
pathogenic yeasts as well as against various dermatophytes. 
The examined strains are listed in Table 1.
First, agar diffusion assay was carried out as described 
previously.20 Briefly, 5 µL of the synthesized AuNP or AgNP 
suspensions (5 mg/mL) were loaded onto the surface of the 
plates seeded by the test strains. The plates were incubated 
at 30°C and the inhibition zones were determined after 
24 hours.
Anti-dermatophyte activity was tested on potato dex-
trose agar (PDA; VWR, Radnor, PA, USA) plates. Agar 
plugs of 3 mm diameter were cut from 4-day-old cultures 
and inoculated upside down onto the surface of PDA plates 
supplemented with AgNP (in 10 or 30 µg/mL concentra-
tion) or with AuNP (first in 10 or 30 µg/mL and later in 
300 µg/mL concentrations). Subsequently, the plates were 
incubated for 4 days at 30°C and the diameter of the colonies 
was measured.
All experiments were carried out at least three times using 
three biological replicates.
Yeast viability assay
The number of colony forming units (CFU) was determined 
to assess the viability of nanoparticle-treated Cr. neoformans 
Table 1 list of the tested strains
Species Strain number
Candida albicans aTcc 10231
Candida glabrata cBs 138
Candida krusei cBs 573
Candida parapsilosis cBs 604
Candida tropicalis cBs 94
Cryptococcus neoformans IFM 5844
Microsporum gypseum sZMc 11124
Trichophyton mentagrophytes sZMc 11102
Trichophyton tonsurans sZMc 11103
Abbreviations: aTcc, american Type culture collection; cBs, centraalbureau 
voor schimmelcultures; IFM, research center for Pathogenic Fungi and Microbial 
Toxicoses, chiba University; sZMc, szeged Microbiology collection.
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cells. Briefly, 4×106 yeast cells in Hanks’ Balanced Salt 
solution (HBSS) were exposed to either AgNP or AuNP 
in concentrations of 1, 5, 10, and 30 µg/mL for 24 hours at 
30°C. After treatment, cells were washed and were resus-
pended in 1 mL sterile water. A tenfold dilution series was 
prepared and 25 µL aliquots from each dilution were spread 
onto YPD plates in triplicates. Non-treated cells were used 
as control. Plates were incubated at 30°C for 72 hours and 
the number of the colonies was counted. The experiments 
were carried out 3 times.
Following AgNP or AuNP treatments, the viability of 
Cr. neoformans cells was examined by calcein-AM assay 
using flow cytometry. Briefly, 4×106 cells were exposed to 
5, 10 or 30 µg/mL AgNPs or to 10 and 30 µg/mL AuNPs in 
HBSS at 30°C for 24 hours. After the treatments, cells were 
washed with sterile distilled water, suspended in 200 µL 
HBSS supplemented with 10 µg/mL verapamil (Sigma-Al-
drich) and were incubated for 20 min at 30°C to block efflux 
transporter activity. Subsequently, calcein-AM (Thermo 
Fisher Scientific) was added in 10 µM concentration and the 
suspensions were further incubated in the dark at 30°C for 
3 hours. Cells were washed with HBSS and the fluorescent 
intensity was measured by flow cytometer (FlowSight®, 
Amnis-EMD Millipore) using a 488-nm excitation laser.
The time-dependent effect of nanoparticle treatments 
was investigated by exposing 4×106 Cr. neoformans cells in 
1 mL HBSS to AgNP or AuNP in 10 µg/mL concentrations 
at 30°C. After 1-, 3-, 10- and 24-hour treatments, aliquots 
of 100 µL each were taken, and after a washing step were 
re-suspended in 1 mL sterile water. Then tenfold dilution 
series was prepared and from each dilution 25 µL aliquots 
were spread onto the surface of YPD plates. Non-treated cells 
were used as control. The plates were incubated at 30°C for 
72 hours and the number of the colonies was counted. The 
experiments were carried out three times, in three biological 
replicates.
Results
characterization of nanoparticles
Particle morphology and size of the synthesized AgNPs 
and AuNPs were determined by TEM image analysis. 
According to the obtained TEM micrographs, AgNPs were 
quasi-spherical, well separated from each other and minor 
polydispersity could be observed (Figure 1A). The aver-
age size of the AgNPs proved to be 4.1±1.44 nm. Gold 
particles were almost monodispersed, well separated and 
spherical with a narrow size distribution (2.22±0.7 nm). 
DLS measurements were also carried out to determine 
hydrodynamic particle sizes (Figure 1B). The average size 
of AgNPs was between 5 and 9 nm diameter, whereas the 
size of gold nanoparticles was around 4–7 nm. The forma-
tion of metal nanoparticles was ascertained by UV-VIS 
measurements (Figure 1C). The typical surface plasmon 
resonance (SPR) band of AgNPs appeared around 455 
nm. UV-VIS spectra of AuNPs showed absorption peak 
maxima at 541 nm characteristic to SPR, which further 
supported the formation of metallic gold nanoparticles. In 
order to confirm the crystalline nature of the nanoparticles, 
XRD analysis was performed. The XRD pattern of the 
AgNP sample (Figure 1D) exhibited four identical diffrac-
tion peaks appearing at 2θ =38.4°, 44.4°, 64.7° and 77.5° 
corresponding to (111), (200), (220) and (311) planes of the 
face-centered cubic lattice structure of metallic silver21 (Joint 
Committee on Powder Diffraction Standards [JCPDS] No 
87-0717). Crystallinity of the as-synthesized AuNPs was 
also investigated. Gold nanocrystals exhibited four distinct 
peaks at 2θ =39.4°, 44.5°, 65.7° and 78.6° corresponding to 
(111), (200), (220) and (310) Bragg’s reflection based on the 
face-centered cubic structure of metallic gold (Figure 1D) 
(JCPDS No 4-0784).22
Toxicity on human cells
We assessed the cell viability of human skin-derived kera-
tinocyte HaCaT cells treated with biologically synthesized 
AgNPs and AuNPs. MTT assays revealed that the nano-
particles, both AgNPs and AuNPs, applied in 0–60 µg/mL 
concentrations, did not reduce the viability of HaCaT cells 
(Figure 2A). On the other hand, treatments with the well-
known therapeutic agent cisplatin caused considerable 
cytotoxicity, since significant loss of keratinocyte metabolic 
activity was observed already at 5 µg/mL cisplatin concentra-
tion (Figure 2A).
Cytotoxicity of AgNPs and AuNPs was analyzed by 
the crystal violet staining method (Figure 2B). AgNPs and 
AuNPs generated by P. rhodozyma cell-free extract were 
non-toxic to the applied human cells in the tested concentra-
tion range. Conversely, cisplatin proved to be significantly 
toxic to human HaCaT cells. These results indicate that these 
biogenic AgNPs and AuNPs exhibit no toxicity therefore 
both are biocompatible to human keratinocytes.
Efficiency against pathogenic yeasts
The antifungal activity of the prepared AgNPs and AuNPs 
was tested against various Candida and Cryptococcus spe-
cies. AgNPs inhibited the growth of all the examined strains 
in agar diffusion assay except that of Candida tropicalis 
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(Figure 3A). Interestingly, Cr. neoformans was sensitive to 
AuNPs as well, whereas other species exhibited resistance 
against AuNPs (Figure 3A).
Since Cr. neoformans appeared susceptible to both 
nanoparticles, the antifungal effect of AgNPs and AuNPs 
was assessed more quantitatively on this particular strain. 
Hence, Cr. neoformans cells were subjected to different 
concentrations of AgNPs and AuNPs for 24 hours then 
cell viability was determined using colony forming assay 
(Figure 3B). Treatments with 1 µg/mL of either AgNPs or 
AuNPs already resulted in a significant loss of cell viability, 
whereas the number of viable Cr. neoformans cells dropped 
below the detectable level following 30 µg/mL of AuNP or 
AgNP administrations (Figure 3B).
To further test the viability of nanoparticle-treated 
Cr. neoformans cells, calcein-AM staining procedure was 
applied. As expected, increasing concentrations of either 
AgNPs or AuNPs gradually diminished the percentage of 
calcein-positive cells. After 10 µg/mL AgNP administra-
tion, approximately 50% of the cells were alive, while 83% 
of the examined cells were dead when AgNP concentration 
was elevated to 30 µg/mL (Figure 3C). A similar pattern 
was observed when yeast cells were exposed to AuNPs, 
since nanoparticle treatments in 30 µg/mL concentrations 
Figure 1 Physicochemical properties of agNPs and auNPs prepared by Phaffia rhodozyma cell-free extract. Transmission electron microscopic images of agNPs and auNPs 
(A), and size distribution of the nanoparticles by Dls measurements (B), UV-VIs spectra (C) and X-ray diffraction pattern (D).
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; Dls, dynamic light scattering; UV-VIs, ultraviolet-visible.
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decreased the percentage of the viable cells to approximately 
50% (Figure 3C). 
Time dependence of the nanoparticle-induced antifungal 
effect was also determined. For this purpose, Cr. neoformans 
cells were again subjected to 10 µg/mL AgNPs or AuNPs 
and after 1-, 3-, 10- and 24-hour treatments the number of the 
colonies was counted. Exposure to AgNPs for 1 hour caused 
a 50% decrease in the number of the CFU, but 10-hour treat-
ments with either AgNPs or AuNPs reduced the number of 
viable cells below 10% (Figure 3D).
anti-dermatophyte activity
All the three examined dermatophyte species were sensitive 
to AgNP treatments in growth inhibition assay (Figure 4). 
AgNPs in 30 µg/mL concentration induced significant inhi-
bition of colony growth, as the diameters of the colonies 
were markedly smaller, indicating an approximately 80% 
growth inhibition for each strain (Figure 4). On the other 
hand, none of the dermatophyte species reacted to AuNPs, 
when applied in 10 or 30 µg/mL concentrations. Therefore, 
AuNP concentration was elevated up to 300 µg/mL but still 
no inhibition was detected (data not shown), indicating that 
AuNPs are not suitable for the growth inhibition of the exam-
ined cutaneous mycosis-causing dermatophyte fungi.
Discussion
Emerging problems associated with antibiotic-resistant 
microbes demanded new strategies to find novel antimi-
crobial agents.23,24 Due to their broad spectrum activity, 
silver-containing materials have been used as antiseptics and 
disinfectants for decades,25 however the potential application 
of colloidal gold for medical purposes has only recently been 
recognized.26 Physical and chemical methods are generally 
considered as standard approaches for nanoparticle prepa-
ration, nevertheless these procedures lead to the accumula-
tion of environmentally hazardous wastes.27 Furthermore, 
the presence of chemical residues within the nanoparticle 
colloid solutions limits their biomedical utilization.28 Bio-
logical synthesis is regarded as an eco-friendly and cost-
effective alternative for the production of biocompatible 
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Figure 2 cytotoxic effects of agNPs and auNPs on hacaT human keratinocyte cells. Viability of the cells was detected by MTT assay after 24 h treatments of agNPs 
or auNPs (A). cytotoxicity of agNPs and auNPs was determined by crystal violet staining; representative images of crystal violet stained cells are shown below column 
diagrams (B). cisplatin was used as a positive control.
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; OD, optical density.
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nanoparticles.29 The numerous publications reporting either 
living microorganisms, plants or cell-free extracts for the 
synthesis of nanomaterials highlight this rapidly expanding 
field of bionanotechnology.15,30
In this study, we investigated the suitability of P. rhodozyma 
cell-free extract for AuNP and AgNP preparation, since 
this microbe contains an effective antioxidant, astaxanthin 
in high concentration, which promotes the formation of 
metal nanoparticles.31 AgNPs and AuNPs were successfully 
synthesized and the biological activities of the as-prepared 
nanoparticles were subjected to complex analysis. AgNPs 
were effective against all the examined mycosis-causing 
fungal species, except for C. tropicalis. Most importantly, 
these biosynthesized silver particles were capable of inhibit-
ing the growth of several opportunistic Candida or Crypto-
coccus species and were highly potent against filamentous 
Microsporum and Trichophyton dermatophytes. In addition, 
AgNPs were biocompatible, showing no cytotoxicity to 
human HaCat keratinocytes, which renders these biosyn-
thesized AgNPs attractive candidates for further biomedical 
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Figure 3 antifungal activity of agNPs and auNPs, agar diffusion assay and the size of the inhibition zones (A). survival rate of Cryptococcus neoformans after agNP or auNP 
treatment determined by the establishment of the cFU (B) and flow cytometry (D). Time-dependent survival of Cr. neoformans cells after exposure to 10 µg/ml agNPs and 
auNPs (C). *Two-way aNOVa p#0.05.
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; cFU, colony forming units; nd, non-detectable.
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Figure 4 anti-dermatophyte activity of silver nanoparticles. (A) colonies of Trichophyton tonsurans (1), Microsporum gypseum (2) and Trichophyton mentagrophytes (3) on PDa 
and PDa supplemented with different concentrations of agNP. (B) The bar charts represent the diameter of the colonies in the function of agNP concentration. #Unpaired 
t-test p#0.05.
Abbreviations: agNP, silver nanoparticle; PDa, potato dextrose agar.
and pharmacological applications. It is also noteworthy that 
among the tested species only Cr. neoformans was suscep-
tible to both AgNPs and AuNPs. We believe this is a relevant 
finding, since mainly antibacterial features of AuNPs have 
been demonstrated so far,32–34 while the scientific litera-
ture is short on investigations into the potential antifungal 
feature of AuNPs.35,36 Importantly, apart from their capacity 
to inhibit Cr. neoformans, gold nanoparticles exerted no 
toxicity on human keratinocytes. These results emphasize 
the potential of such biosynthesized nanoparticles in topical 
dermatologic therapeutic strategies. Since cutaneous mycosis 
has the highest incidence among fungal infections,1,2,37 cost-
effective, novel treatment modalities should be introduced 
into the related clinical practice. The symptoms can range 
from subclinical (eg, itching, rash), to serious inflammatory 
reactions (eg, blistering, scarring, alopecia), requiring dis-
tinct treatment regimens. Furthermore, the infective species 
can induce severe complications in immunocompromised 
individuals, including organ transplant, hematology and 
oncology patients where the infected area can manifest ulcer-
ation or even tissue necrosis.3 The severity of these symptoms 
should be attenuated by complementary management using 
topical treatment approaches. We believe that biosynthesized 
metal nanoparticles could be implemented to improve the 
clinical outcome of cutaneous mycosis.
Conclusion
We found that the cell-free extract of P. rhodozyma is a 
suitable material for the synthesis of biogenic AgNPs and 
AuNPs. We demonstrated that these nanoparticles are 
potent against cutaneous mycosis-causing dermatophytes 
and opportunistic yeast species and are non-toxic to human 
keratinocytes. Considering our data in the context of the 
current clinical results, the biocompatibility to skin cells and 
the outstanding antifungal performance of our biosynthesized 
nanoparticles might be exploited during topical treatment of 
cutaneous mycosis or as a prophylactic treatment against the 
recurrence of the infection.
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